Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street Ueno Bldg, 8F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA 1-9-10 Nihonbashi-Horidome cho, Chuo-ku
Tel +41 58 595 2021 Tel +1 888 422 2436 Tokyo 103-0012 - Japan
Fax +41 58 595 2040 Tel +1 888 4BACHEM Tel +81 3 6661 0774
Email Fax +1 310 539 9428 Email


Fiscal year 2016: Another year of strong sales and profit growth

17. Mar 2017
  • Momentum intact and new sales record set
  • EBIT margin climbs to 19.1%, EBITDA margin to 27.4%
  • Significantly faster net income growth of 29.4% to 41.2 million CHF
  • Expansion of production capacity, new building for R&D at company headquarters
  • Workforce grows, now numbers more than 1’000
  • Increase in dividend from 2.25 to 2.50 CHF proposed
  • Excellent order situation and better capacity utilization


Bubendorf/Basel, Friday, March 17, 2017 – Bachem Group (SIX: BANB), the market leader in the field of peptide chemistry with a distinctive focus on quality and innovation, set another sales record in the 2016 fiscal year and reported sharply higher earnings. Bachem managed to sustain its very good momentum from the first half of the year throughout the second half. The Group generated full-year sales of 236.5 million CHF (2015: 208.6 million CHF, +13.4% in CHF). Bachem increased its operating profit (EBIT) by 17.0% to 45.1 million CHF. One-off costs associated with legal counsel and the introduction of a new Group-wide Enterprise Resource Planning (ERP) system are included in this figure. Furthermore, the expansion of capacity at American Peptide Company (APC) after its acquisition in 2015 resulted in a brief, scheduled stoppage in production that curtailed the utilization of the Vista, California plant. Despite these extraordinary effects, Bachem widened its EBIT margin to 19.1% (previous year: 18.5%). The EBITDA margin stood at 27.4% (previous year: 27.2%). Net income rose at a proportionately faster pace of 29.4% with some tailwind from positive foreign exchange effects and amounted to 41.2 million CHF (previous year: 31.8 million CHF).

Press release